Showing results (41-50 of 302) with videos related to

Sort By:
Pageof 31
International Journal of Colorectal Disease|December 1, 2014
A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancerFausto Petrelli, Andrea Coinu, Veronica Lonati, et al.
Anti-Cancer Drugs|May 18, 2016
Mitomycin-C+fluoropyrimidines in heavily pretreated metastatic colorectal cancer: a systematic review and evidence synthesisFausto Petrelli, Antonio Ghidini, Alessandro Inno, et al.
Annals of Surgery|November 23, 2013
Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published StudiesFausto Petrelli, Giovanni Sgroi, Enrico Sarti, et al.
Future Oncology (London, England)|April 3, 2015
Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologistsSandro Barni, Elena Collovà, Antonio Frassoldati, et al.
Clinical Advances in Hematology & Oncology : H&O|February 20, 2008
Creating real benefit for patients at risk of nausea and vomiting: palonosetron-from bench to bedsideCamilo Rojas, Steven Grunberg, Giovanni Rosti
Current Opinion in Oncology|May 10, 2011
Nutritional intervention for improving treatment tolerance in cancer patientsAgostino Paccagnella, Ildamaria Morassutti, Giovanni Rosti
Clinical Breast Cancer|June 11, 2016
Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III StudiesFausto Petrelli, Serena Di Cosimo, Veronica Lonati, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 14, 2015
Progression-free survival as surrogate endpoint in advanced pancreatic cancer: meta-analysis of 30 randomized first-line trialsFausto Petrelli, Andrea Coinu, Karen Borgonovo, et al.
Expert Review of Anticancer Therapy|November 27, 2012
Biological agents alone or in combination as second-line therapy in advanced non-small-cell lung cancer: systematic review of randomized studiesFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Medical Oncology (Northwood, London, England)|July 6, 2013
KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trialsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Pageof 31